Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | October 2018

An Interview With Guilherme Dabus, MD, FAHA

Dr. Dabus discusses the rapidly evolving field of neurointerventional stroke care, areas that require further study and efforts, and the path that led him to find his passion for this specialty.

evt | Article | February 2019

Next Horizons in Neurointervention

By Guilherme Dabus, MD, FAHA

evt | Article | August 2017

Basilar Thrombus and Occlusion of the Left Vertebral Artery

Moderator: Guilherme Dabus, MD, FAHA
Panel: Donald Frei, MD; Ansaar T. Rai, MD, MBA; and Sudhakar R. Satti, MD

evt | Article | April 2013

Interventional Treatment Options for Vascular Malformations

Approaches, techniques, and sclerosing and embolic agents that can be used in low- and high-flow vascular malformations.

By Guilherme Dabus, MD, and James F. Benenati, MD

Advertisement

Sponsored by Penumbra, Inc.

evt | Article | February 2016

Penumbra System® for Intracranial Mechanical Thrombectomy

Experts discuss the effectiveness of this system for the fast and efficient removal of intracranial thrombi.

With James M. Milburn, MD; Donald F. Frei, MD; Jeffrey L. Groffsky, MD; Blaise Baxter, MD; Jeffrey Farkas, MD; Guilherme Dabus, MD; and Ian Kaminsky, MD

evt | News | August 14, 2024

SNIS Names Dr. Johanna T. Fifi as President for 2024-2025

August 14, 2024—The Society of NeuroInterventional Surgery (SNIS) announced that Johanna T. Fifi, MD, an interventional neurologist at Mount Sinai Hospital in New York, New York, has been named the society’s 2024–2025 president.

evt | News | February 21, 2024

Route 92 Medical Completes Enrollment in SUMMIT MAX RCT of HiPoint Reperfusion Catheters

February 21, 2024—Route 92 Medical, Inc., a medical technology company dedicated to neurovascular intervention, announced the completion of enrollment in its 250-patient SUMMIT MAX clinical trial.

evt | Article | April 2013

Decisions in Embolization

By Barry T. Katzen, MD

evt | Article | August 2017

Real-World Decision Making

By John A. Kaufman, MD

evt | News | May 21, 2025

Route 92 HiPoint 88 Reperfusion System Cleared by FDA

May 21, 2025—Route 92 Medical, Inc. announced FDA 510(k) clearance (product code: NRY) for the company’s HiPoint reperfusion system, which includes the HiPoint 88 reperfusion system with the Tenzing 8 delivery catheter and featuring the Monopoint approach.

evt | Article | July 2020

Stroke Care Trends During the COVID-19 Pandemic

Three neurointerventionalists share their experiences treating stroke amidst the pandemic, thoughts on why some institutions are seeing a lower incidence of stroke, and a look at the Society for NeuroInterventional Surgery’s public awareness initiative.

With Dorothea Altschul, MD, FAHA; Richard P. Klucznik, MD; and James Milburn, MD, FACR

evt | News | February 8, 2022

Route 92 Medical’s Monopoint Reperfusion System Studied in Pivotal SUMMIT MAX Trial

February 8, 2022—Route 92 Medical, Inc., a medical technology company focused on acute ischemic stroke intervention, announced the first patient enrollment in its SUMMIT MAX clinical trial of the company’s next-generation Monopoint reperfusion system.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button